$22.41 -0.48 (-2.10%)
11/27/2009 9:43 AM

Endo Pharmaceuticals (ENDP)

CAPS Rating: 5 out of 5

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

Results 1 - 3 of 3

Recs

0
Member Avatar tortillatree (82.50) Submitted: 7/22/2009 10:03:39 AM : Underperform Start Price: $19.25 ENDP Score: -2.13

Earnings are coming out in 9 days, and it won't look good because of all their acquisitions and research and court fees this quarter. Long term, it's still a buy, but I'm out for a few weeks. I'll get back in when things settle down.

Recs

0
Member Avatar MNNice (< 20) Submitted: 2/8/2009 9:59:56 AM : Underperform Start Price: $23.38 ENDP Score: +31.53

ENDP is being sued by Lectec corp for patent infringement of Lectec's transdermal patch technology. On Friday, Feb 6th, Lectec filed a preliminary injunction against the defendants. The motion is very strong. Lectec has two re-examined patents...no re-examined patent has ever been found invalid in a court of law. A top legal firm, Radar, and the case is being tried in Texarcana, the rocket-docket that's also very plaintiff friendly in patent infringement lawsuits. Lectec has an expert witness, Dr. Guy. Many other witnesses and documents will come to light.

Recs

0
Member Avatar EagleTraderOne (81.39) Submitted: 9/10/2008 4:56:00 PM : Underperform Start Price: $20.76 ENDP Score: -15.93

In this climate and this sector. ENDP is way overpriced.

Results 1 - 3 of 3

Featured Broker Partners